|
The FDA is looking for new members for ODAC: here is the information. If
you are interested, follow these instructions:
The Food and Drug Administration is requesting nominations for members to
serve on the Oncologic Drugs Advisory Committee (ODAC) in the Center for
Drug Evaluation and Research (CDER), and would like to invite your
organization to participate in the nomination process. Because the terms
for the new Members will start on July 1, 2008, nominations must be received
by March 1, 2008.
If you would like to submit your name, please forward curriculum vitaes to
Nicole Vesely, Pharm.D., Designated Federal Official for the ODAC
Her contact information is
nicole.vesely@fda.hhs.gov
telephone number is 301-821-6793.
Her mailing address is
FDA/CDER, Advisors and Consultants Staff,
5630 Fishers Lane, HFD-21,
Rockvile, MD 20857.
|
